Artigos (8) Publicacións nas que participase algún/ha investigador/a

2020

  1. Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1378-1389

  2. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

  3. Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: A prospective phase II study

    Radiation Oncology, Vol. 15, Núm. 1

  4. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

  5. High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455

  6. Impact of previous admission to an intensive care unit on stem cell transplantation outcome

    Medicina Clinica, Vol. 155, Núm. 9, pp. 382-387

  7. Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy

    Journal of the National Cancer Institute, Vol. 112, Núm. 2, pp. 179-190

  8. SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 67, Núm. 7, pp. 391-399